SCHEMBL10206012

SCHEMBL10206012

c1ccc(-n2c3ccccc3c3ccc4c5ccccc5n(-c5ccc(-c6cc(-n7c8ccccc8c8ccc9c%10ccccc%10n(-c%10ccccc%10)c9c87)nc(-n7c8ccccc8c8ccc9c%10ccccc%10n(-c%10ccccc%10)c9c87)c6)cc5)c4c32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ HDAC4 P56524 1/20 0.37
▸ KMT2A Q03164 4/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ PTGER4 P35408 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ BRCA1 P38398 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ KHK P50053 1/20 0.33
▸ MAT2A P31153 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205995 0.99 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL10029937 0.96 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL10206023 0.96 L3MBTL1 (0.52) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17809204 0.89 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL12265000 0.89 KDM4E (0.42) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17809123 0.89 KDM4E (0.39) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17809198 0.89 KDM4E (0.39) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL10206007 0.88 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL10206008 0.88 L3MBTL1 (0.57) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL16353156 0.88 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2AIL1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10454042-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2019-10-22 — — US disclosed
US-20160079545-A1 Organic Electroluminescence Device UDC Ireland (IE) 2016-03-17 — — US disclosed
US-9287515-B2 Compositions comprising organic and organometallic compounds, and their applications in organic electroluminescence, light emission, display, and illumination devices UDC Ireland (IE) 2016-03-15 — — US disclosed
US-20120153272-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-06-21 — — US disclosed
US-20120153272-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-06-21 — — US disclosed
US-7993760-B2 Compound for use in organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-08-09 — — US disclosed
US-7993760-B2 Compound for use in organic electroluminescent device and organic electroluminescent device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-08-09 — — US disclosed
US-20090302742-A1 Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device NIPPON STEEL CHEMICAL CO., LTD. (JP) 2009-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090302742-A1 Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device LAGE3, ICMT, PPOX L3MBTL1 1565/4885KDM4E 2976/4885ATM 3133/4885
US-10454042-B2 Organic electroluminescence device EML4, ELOC, ORC3 L3MBTL1 770/4885KDM4E 1789/4885ATM 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback